GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) — 分析摘要
GSK plc American Depositary Shares (Each representing two Ordinary Shares)（GSK）的市值为100.28十亿美元，最近一年的营收同比增长了+7.5%。净利润率为19.3%。当前市盈率为12.1倍。
核心要点
- 营收同比变化+7.5%
- 净利润率19.3%
- 市盈率12.1倍
GSK的营收增长为+7.5%，市盈率为12.1倍。
GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
更新 — ET · 市场数据 POLYGON · 财务数据 SEC EDGAR
红旗与风险提示重点关注
当前存在需要关注的风险信号，应与估值结果一并解读。
流动比率为 0.82x — 流动负债超过流动资产
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
员工人数
66,841
Exchange
XNYS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$1.81
股息收益率
3.61%
股息历史
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。